159 related articles for article (PubMed ID: 37478874)
21. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
Staatz CE; Byrne C; Thomson AH
Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
[TBL] [Abstract][Full Text] [Related]
23. Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants.
Germovsek E; Kent A; Metsvaht T; Lutsar I; Klein N; Turner MA; Sharland M; Nielsen EI; Heath PT; Standing JF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4869-77. PubMed ID: 27270281
[TBL] [Abstract][Full Text] [Related]
24. Bayesian forecasting of gentamicin pharmacokinetics in pediatric intensive care unit patients.
Kraus DM; Dusik CM; Rodvold KA; Campbell MM; Kecskes SA
Pediatr Infect Dis J; 1993 Sep; 12(9):713-8. PubMed ID: 8414796
[TBL] [Abstract][Full Text] [Related]
25. DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.
Tasa T; Metsvaht T; Kalamees R; Vilo J; Lutsar I
Ther Drug Monit; 2017 Dec; 39(6):604-613. PubMed ID: 29084032
[TBL] [Abstract][Full Text] [Related]
26. Population Pharmacokinetic Modeling of Vancomycin in Thai Patients With Heterogeneous and Unstable Renal Function.
Jaisue S; Pongsakul C; D'Argenio DZ; Sermsappasuk P
Ther Drug Monit; 2020 Dec; 42(6):856-865. PubMed ID: 32947558
[TBL] [Abstract][Full Text] [Related]
27. [Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].
Nakamura T; Wakaki N; Kimura Y; Goto N; Masada M
Yakugaku Zasshi; 1996 Nov; 116(11):876-83. PubMed ID: 8981831
[TBL] [Abstract][Full Text] [Related]
28. Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.
Carreno JJ; Lomaestro B; Tietjan J; Lodise TP
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289024
[TBL] [Abstract][Full Text] [Related]
29. [A priori prediction of gentamicin peak concentrations: Use of a simple and practical tool].
Mignaval F; Fontaine PA; Riché A; Nowak C; Cancel D; Lemaitre F
Pathol Biol (Paris); 2011 Apr; 59(2):79-82. PubMed ID: 20822863
[TBL] [Abstract][Full Text] [Related]
30. Does calculation method matter for targeting vancomycin area under the curve?
Chang J; Patel D; Vega A; Claeys KC; Heil EL; Scheetz MH
J Antimicrob Chemother; 2022 Jul; 77(8):2245-2250. PubMed ID: 35640658
[TBL] [Abstract][Full Text] [Related]
31. Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates.
Yu CZ; Myers SR; Faldasz JD
Pediatr Infect Dis J; 2020 Apr; 39(4):313-317. PubMed ID: 32032171
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a Bayesian method for predicting vancomycin dosing.
Burton ME; Gentle DL; Vasko MR
DICP; 1989 Apr; 23(4):294-300. PubMed ID: 2728513
[TBL] [Abstract][Full Text] [Related]
33. Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoring.
Aljutayli A; Thirion DJG; Nekka F
Biomed Pharmacother; 2022 Nov; 155():113777. PubMed ID: 36271558
[TBL] [Abstract][Full Text] [Related]
34. Gentamicin and vancomycin removal by continuous venovenous hemofiltration.
Thomson AH; Grant AC; Rodger RS; Hughes RL
DICP; 1991 Feb; 25(2):127-9. PubMed ID: 2058183
[TBL] [Abstract][Full Text] [Related]
35. Prediction of serum vancomycin concentrations using one-, two- and three-compartment models with implemented population pharmacokinetic parameters and with the Bayesian method.
Wu G; Furlanut M
J Pharm Pharmacol; 1998 Aug; 50(8):851-6. PubMed ID: 9751448
[TBL] [Abstract][Full Text] [Related]
36. Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.
Samardzic J; Allegaert K; Wilbaux M; Pfister M; van den Anker JN
Expert Opin Drug Metab Toxicol; 2016; 12(4):367-75. PubMed ID: 26817821
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.
Fewel N
J Clin Pharm Ther; 2021 Oct; 46(5):1426-1432. PubMed ID: 34169543
[TBL] [Abstract][Full Text] [Related]
38. To Estimate or to Forecast? Lessons From a Comparative Analysis of Four Bayesian Fitting Methods Based on Nonparametric Models.
Goutelle S; Alloux C; Bourguignon L; Van Guilder M; Neely M; Maire P
Ther Drug Monit; 2021 Aug; 43(4):461-471. PubMed ID: 34250963
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
Hiraki Y; Onga T; Mizoguchi A; Tsuji Y
J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677
[TBL] [Abstract][Full Text] [Related]
40. Generation of pharmacokinetic data during routine therapeutic drug monitoring: Bayesian approach vs. pharmacokinetic studies.
el Desoky E; Meinshausen J; Bühl K; Engel G; Harings-Kaim A; Drewelow B; Klotz U
Ther Drug Monit; 1993 Aug; 15(4):281-8. PubMed ID: 8236362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
